Model | Variable | Model 1 | Model 2 | Model 3 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common variables | PCS | MCS | PCS | MCS | PCS | MCS | |||||||
Coeff | p | Coeff | p | Coeff | p | Coeff | p | Coeff | p | Coeff | p | ||
Model 1 | Country | ||||||||||||
Australia | reference | - | 1.05 | 0.10 | reference | - | 1.04 | 0.19 | reference | - | 1.06 | 0.08 | |
China | 1.04 | 0.09 | reference | - | 1.06 | 0.02 | reference | - | 1.05 | 0.04 | reference | - | |
Indonesia | 1.01 | 0.73 | 1.06 | 0.04 | 1.02 | 0.40 | 1.07 | 0.03 | 1.02 | 0.45 | 1.07 | 0.02 | |
Philippines | 1.10 | <0.001 | 1.17 | <0.001 | 1.12 | <0.001 | 1.18 | <0.001 | 1.12 | <0.001 | 1.19 | <0.001 | |
Singapore | 1.08 | <0.01 | 1.12 | <0.001 | 1.09 | <0.001 | 1.12 | <0.001 | 1.09 | <0.001 | 1.13 | <0.001 | |
Taiwan | 1.06 | 0.01 | 1.04 | 0.08 | 1.07 | <0.01 | 1.03 | 0.15 | 1.06 | 0.01 | 1.03 | 0.14 | |
Thailand | 1.04 | 0.11 | 1.02 | 0.33 | 1.05 | 0.06 | 1.02 | 0.39 | 1.04 | 0.12 | 1.02 | 0.30 | |
Ethnicity | |||||||||||||
Caucasian | reference | - | reference | - | reference | - | reference | - | reference | - | reference | - | |
Asian | 1.10 | <0.001 | 1.02 | 0.50 | 1.10 | <0.001 | 1.02 | 0.62 | 1.10 | <0.001 | 1.02 | 0.53 | |
Education | |||||||||||||
Primary | reference | - | reference | - | reference | - | reference | - | reference | - | reference | - | |
Secondary | 1.03 | 0.03 | 1.03 | 0.12 | 1.03 | 0.03 | 1.03 | 0.16 | 1.03 | 0.04 | 1.03 | 0.13 | |
Tertiary | 1.05 | 0.002 | 1.06 | <0.01 | 1.05 | 0.001 | 1.06 | <0.01 | 1.05 | 0.001 | 1.06 | <0.01 | |
Age at diagnosis (years) | 0.997 | <0.001 | 1.00 | 0.39 | 0.997 | <0.001 | 1.00 | 0.39 | 0.997 | <0.001 | 1.00 | 0.37 | |
Disease duration (years) | 0.998 | 0.05 | 1.00 | 0.06 | 0.998 | <0.01 | 1.00 | 0.08 | 0.998 | <0.01 | 1.00 | 0.10 | |
SLICC-DI score | 0.96 | <0.001 | 0.99 | 0.13 | 0.96 | <0.001 | 0.99 | 0.21 | 0.97 | <0.001 | 0.99 | 0.15 | |
LLDAS | 1.06 | <0.001 | 1.05 | <0.001 | - | - | - | - | - | - | - | - | |
Model 2 | SLEDAI score | - | - | - | - | 0.997 | 0.05 | 1.00 | 0.35 | - | - | - | - |
PGA (0–3) | - | - | - | - | 0.95 | <0.001 | 0.97 | 0.02 | - | - | - | - | |
Mild flare | - | - | - | - | 0.98 | 0.26 | 0.98 | 0.25 | - | - | - | - | |
Severe flare | - | - | - | - | 0.97 | 0.11 | 0.97 | 0.33 | - | - | - | - | |
Prednisolone (mg) | - | - | - | - | 0.998 | 0.01 | 0.999 | 0.13 | - | - | - | - | |
Model 3 | Current organ activity | ||||||||||||
Renal | - | - | - | - | - | - | - | - | 1.00 | 0.43 | 1.02 | 0.29 | |
MSK | - | - | - | - | - | - | - | - | 0.93 | <0.001 | 0.99 | 0.55 | |
Vasculitis | - | - | - | - | - | - | - | - | 0.99 | 0.84 | 1.02 | 0.74 | |
Cutaneous | - | - | - | - | - | - | - | - | 0.95 | 0.70 | 0.94 | 0.04 | |
Serositis | - | - | - | - | - | - | - | - | 0.96 | 0.34 | 1.04 | 0.49 | |
PGA (0–3) | - | - | - | - | - | - | - | - | 0.99 | <0.001 | 0.97 | 0.03 | |
Mild flare | - | - | - | - | - | - | - | - | 0.99 | 0.59 | 0.99 | 0.58 | |
Severe flare | - | - | - | - | - | - | - | - | 0.96 | 0.04 | 0.98 | 0.36 | |
Prednisolone (mg) | - | - | - | - | - | - | - | - | 0.998 | <0.01 | 0.999 | 0.19 |